A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855 | PMC |
| http://dx.doi.org/10.1007/s15010-020-01476-7 | DOI Listing |
Publication Analysis
Top Keywords
baricitinib rescue
4
rescue therapy
4
therapy patient
4
patient covid-19
4
covid-19 complete
4
complete response
4
response sarilumab
4
sarilumab patient
4
patient covid-19-related
4
covid-19-related severe
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!